Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

Market Cap	11.83B +48.1%
Revenue (ttm)	1.63B +19.8%
Net Income	157.25M +58.5%
EPS	0.59 +56.1%
Shares Out	264.98M
PE Ratio	75.78
Forward PE	40.60
Dividend	0.02 (0.03%)
Ex-Dividend Date	n/a

Volume	10,926,899
Open	56.60
Previous Close	46.16
Day's Range	44.40 - 56.60
52-Week Range	30.25 - 90.68
Beta	-0.33
Analysts	Strong Buy
Price Target	70.00 (+56.74%)
Earnings Date	Aug 26, 2026

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liver disease; and FibroView data management software. It provides digital health management services; compound turtle shell softening liver tablets; and ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 946
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300049

Financial Performance

In 2025, SHE:300049's revenue was 1.60 billion, an increase of 18.26% compared to the previous year's 1.35 billion. Earnings were 154.09 million, an increase of 36.02%.